Physician profile
Shane E Ford
NPI 1497714075
$2,701.46
in general payments reported to CMS, 2019-2025
17 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $267 · 2021: $235 · 2022: $545 · 2023: $688 · 2024: $347 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,447 · Entertainment: $15.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,446.65 |
| Entertainment | $15.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,514.52 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $441.78 | 2019-2023 | Acuvue |
| Oyster Point Pharma, INC. | $107.25 | 2022-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $107.01 | 2023-2024 | Vyzulta, Miebo, Infuse |
| Novartis Pharmaceuticals Corporation | $101.19 | 2019-2023 | |
| Shire North American Group INC | $68.43 | 2019 | |
| Allergan, INC. | $59.06 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $49.09 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $47.26 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $39.91 | 2022-2025 | |
| Abbvie INC. | $38.64 | 2024-2025 | |
| Biotissue Holdings INC. | $37.82 | 2020-2021 | |
| Harrow Eye, LLC | $23.31 | 2024 | Vevye |
| Lumibird Medical INC. | $23.08 | 2021 | |
| Optos, INC. | $15.26 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $14.30 | 2021 | |
| Eyevance Pharmaceuticals LLC | $13.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.